Axcella Health Inc. (AXLA)
4.58
0.00 (0.00%)
At close: Jan 16, 2025, 9:00 PM
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST
undefined% (undefined)
| Bid | n/a |
| Market Cap | 0 |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -18.25 |
| PE Ratio (ttm) | -0.25 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 0 |
| Avg. Volume (20D) | 0 |
| Open | undefined |
| Previous Close | 4.58 |
| Day's Range | 4.58 - 4.58 |
| 52-Week Range | 4.58 - 4.58 |
| Beta | undefined |
About AXLA
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well a...
Industry Biotechnology
Sector Healthcare
IPO Date May 9, 2019
Employees 11
Stock Exchange NASDAQ
Ticker Symbol AXLA
Website https://www.axcellahealth.com